Bortezomib/dexamethasone explained

Type:combo
Component1:Bortezomib
Class1:Proteasome inhibitor
Component2:Dexamethasone
Class2:Corticosteroid
Tradename:Vel/Dexm, Vel-Dex, and Veldex
Legal Us:Rx-only

Bortezomib/dexamethasone is a combination drug against multiple myeloma.[1] When bortezomib is used by the trade name Velcade, the combination is called Vel/Dex (or Vel-Dex or Veldex). Bortezomib is a proteasome inhibitor and dexamethasone is a corticosteroid.

Notes and References

  1. Corso A, Barbarano L, Mangiacavalli S, Spriano M, Alessandrino EP, Cafro AM, Pascutto C, Varettoni M, Bernasconi P, Grillo G, Carella AM, Montalbetti L, Lazzarino M, Morra E . 6 . Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma . Leukemia & Lymphoma . 51 . 2 . 236–42 . February 2010 . 20001242 . 10.3109/10428190903452826 . 25932724 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bortezomib/dexamethasone".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.